Given the upregulated expressions of NUDT21 and LDHA in ESCC and their association with cuproptosis resistance (Supplementary Fig. S10h), targeting lactylated NUDT21 emerges as a prospective strategy. The gene discussed is LDHA; the disease is esophageal squamous cell carcinoma.